Top section
Top section
◆ Have capital markets comprehended the heatwave? ◆ Which SSA issuers need to get it done this autumn ◆ Halcyon days for MTN, M&A and ECM bankers
Investors pay little heed to alarming worsening of climate
New $75m partnership to develop treatment for lymphoma was “catalyst for investors”
More articles
More articles
More articles
-
Some EU member states are nearing a compromise on a common financial transactions tax, something that has been discussed for almost a decade in the bloc, but has failed to materialise up to now. -
Shares in Serco, the UK outsourcing company, rose more than 8% on Thursday morning after the company announced a £130m growth capital raise to finance the takeover of Alion’s naval design and systems engineering business, a leading supplier of services to the US armed forces.
-
France is ready to relaunch its stalled privatisation programme with the IPO of Française des Jeux (FDJ), the national lottery operator and sports betting company. Sam Kerr reports.
-
Biopharmaceuticals company Mabpharm launched bookbuilding for its up to HK$1.53bn ($195m) flotation, while Hansoh Pharmaceutical Group set pre-marketing in motion for its Hong Kong listing.
-
Mulsanne Group Holding broke new ground this week by pricing its IPO below the initial marketed range, debuting a mechanism introduced to the Hong Kong stock market just last year. The move could become more common in the city if US-China trade tensions continue to ramp up market volatility, according to equity capital markets bankers. Jonathan Breen reports.
-
BNP Paribas has appointed Bruno Villard as head of M&A for Europe, the Middle East and Africa.
Sub-sections
shared comment list
